CD56
Showing 1 - 25 of 3,521
Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)
Recruiting
- Extranodal NK T Cell Lymphoma
- NK-Cell Leukemia
- Anti-CD56 CAR T
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023
Malignant Disease Trial in Shenzhen (bi-4SCAR GD2/CD56 T cells)
Recruiting
- Malignant Disease
- bi-4SCAR GD2/CD56 T cells
-
Shenzhen, Guangdong, ChinaShenzhen Geno-immune Medical Institute
Jun 25, 2022
Hematologic Malignancies Trial in Assiut (CD56)
Recruiting
- Hematologic Malignancies
- CD56
-
Assiut, Egypt
- +1 more
Jul 20, 2022
Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56
Not yet recruiting
- Acute Myeloid Leukemia
- bone marrow aspirate and biopsy
- (no location specified)
Aug 20, 2022
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)
Active, not recruiting
- Multiple Myeloma
- +4 more
- Total Body Irradiation
- +5 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 21, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Acute Myelogenous Leukemia Trial in Chicago, Minneapolis, Columbus (Interventions)
Terminated
- Acute Myelogenous Leukemia
- Interventions
-
Chicago, Illinois
- +2 more
Jul 8, 2020
Recurrent Pregnancy Loss Trial in Maastricht, Nijmegen (Exercise)
Recruiting
- Recurrent Pregnancy Loss
- Exercise
-
Maastricht, Netherlands
- +1 more
Aug 22, 2023
Healthy Trial in Taipei (Vitamin D, Medium-chain triglycerides)
Completed
- Healthy
- Vitamin D
- Medium-chain triglycerides
-
Taipei, TaiwanTaipei Medical University
Mar 9, 2023
Healthy Trial in Taipei (Vitamin D, Medium-chain triglycerides)
Active, not recruiting
- Healthy
- Vitamin D
- Medium-chain triglycerides
-
Taipei, TaiwanTaipei Medical University
Mar 10, 2023
Healthy Trial in Taipei (maca, )
Active, not recruiting
- Healthy
- maca
- placebo
-
Taipei, TaiwanTaipei Medical University
Mar 9, 2023
Colorectal Cancer, Colorectal Tumors Malignant, Intestinal Tumors, Malignant Trial in Shanghai (Ileostomy, Transverse colostomy)
Recruiting
- Colorectal Cancer
- +2 more
- Ileostomy
- Transverse colostomy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
May 2, 2023
Healthy Trial in Aalborg (Blood sample)
Recruiting
- Healthy
- Blood sample
-
Aalborg, Denmark• The Centre for Recurrent Pregnancy Loss of Western Denmark, De
Nov 2, 2022
B-cell NHL, CLL Trial (CARCIK-CD19)
Not yet recruiting
- B-cell NHL
- CLL
- CARCIK-CD19
- (no location specified)
May 19, 2023
Patients Receiving Mismatched Allogeneic HCT Trial in Germany (immunosuppression)
Terminated
- Patients Receiving Mismatched Allogeneic HCT
-
Mainz, Germany
- +3 more
Jun 29, 2022
Relapsed Hematologic Malignancy Trial in Bergamo (donor-derived CIK cells)
Recruiting
- Relapsed Hematologic Malignancy
- donor-derived CIK cells
-
Bergamo, ItalyA O Papa Giovanni XXIII
Dec 22, 2021
Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
-
Essen, GermanyUniversity Hospital Essen
Nov 2, 2022
Stress Trial in Miami (Cognitive behavioral stress management, Psychoeducational Control)
Completed
- Stress
- Cognitive behavioral stress management
- Psychoeducational Control
-
Miami, FloridaUniversity of Miami
Aug 2, 2022
NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)
Recruiting
- Non-small Cell Lung Cancer
- Hypofractionated radiotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Nov 14, 2023
Clot Analysis in Stroke Patients
Recruiting
- Stroke, Acute
- +2 more
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli, IRCCS
Feb 27, 2023
Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))
Recruiting
- Malignant Sarcoma
- Natural Killer (NK) cells (a new immunotherapy)
-
Madrid, SpainHospital Universitario La Paz
Jul 19, 2023
Advanced Liver Cancers Trial (DC-CIK)
Not yet recruiting
- Advanced Liver Cancers
- DC-CIK
- (no location specified)
Nov 11, 2022